situ hibridizasyon yöntemi i - Çukurova Üniversitesi

142. Bauer J, Bastian BC at al, Distinguishing melanocytic nevi from melanoma by DNA copy
number changes: comparative genomic hybridization as a research and diagnostic tool. Dermatol.
Ther 2006; 19; 40–49.
143. Karan K. Sra at al. Stephen K. Tyring, MD, PhD, MBA Molecular Diagnosis of Cutaneous
Diseases Arch Dermatol 2005; 141:225-241
144. Lee JD, at al Interphase cytogenetic analysis of 1q12 satellite III DNA in melanocytic lesions:
increased aneuploidy with malignant histology. Am. J. Dermatopathol. 2001; 23: 176–180.
145. Wettengel GV at al Differentiation between Spitz nevi and malignant melanomas by interphase
fluorescence in situ hybridization. Int J. Oncol. 1999; 14; 1177–1183
146. Albertson DG, Collins C, et al. Chromosome aberrations in solid tumors [review]. Nat Genet.
2003; 34(4):369–376.
147. Bastian BC. Understanding the progression of melanocytic neoplasia using genomic analysis:
from fields to cancer [review]. Oncogene. 2003; 22 (20): 3081–3086
148. Boris C. Bastian at al, Chromosomal Gains and Losses in Primary Cutaneous Melanomas
Detected by Comparative Genomic Hybridization cancer research 58. May 15. 1998; 2170-2175.
149. Boris C. Bastiann, Understanding the progression of melanocytic neoplasia using genomic
analysis: from fields to cancer Oncogene 2003; 22, 3081–3086
150. Chan SR, Blackburn EH. Telomeres and telomerase. Philos Trans RSoc Lond B Biol Sci, 2004;
359:109–21.
151. Palm W, de Lange T. How shelterin protects mammalian telomeres. Annu Rev Genet 2008;
42:301–34.
152. Barnhill RL, Argeny ZB, From L, et al. Atypical Spitz nevi/tumors: lack of consensus for
diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol 1999; 30:513.
153. Corona R. at al. İnterobserver variability on the histopathologic diagnosis of cutaneous melanoma
and other pigmented skin lesions. J Clin Oncol.1996;14: 1218-1223.
154. Lodha S, Saggar S, Celebi JT. at al. Discordance in the histopathologic diagnosis of difficult
melanocytic neoplasms in the clinical setting. J Cutan Pathol. 2008; 35: 349-352
155. Gerami P, Mafee M, et al. Sensitivity of fluorescence in situ hybridization for melanoma
diagnosis using RREB1, MYB, Cep 6 ve 11q13 probes melanoma subtypes, Arch Dermathol
.2010; 273-278
102